AR025498A1 - A NEW PHARMACEUTICAL ASSOCIATION THAT PRESENTS AN ANALGESIC EFFECT - Google Patents

A NEW PHARMACEUTICAL ASSOCIATION THAT PRESENTS AN ANALGESIC EFFECT

Info

Publication number
AR025498A1
AR025498A1 ARP000104630A AR025498A1 AR 025498 A1 AR025498 A1 AR 025498A1 AR P000104630 A ARP000104630 A AR P000104630A AR 025498 A1 AR025498 A1 AR 025498A1
Authority
AR
Argentina
Prior art keywords
presents
pharmaceutical association
new pharmaceutical
analgesic effect
new
Prior art date
Application number
Other languages
Spanish (es)
Original Assignee
Union Pharma Scient Appl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Union Pharma Scient Appl filed Critical Union Pharma Scient Appl
Priority to ARP000104630 priority Critical patent/AR025498A1/en
Publication of AR025498A1 publication Critical patent/AR025498A1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Una nueva asociacion farmacéutica, que comprende a título de principios activos asociados, paracetamol y buspirona o una de sus sales farmacéuticamenteaceptables. Su aplicacion es para el tratamiento del dolor.A new pharmaceutical association, comprising as associated active ingredients, paracetamol and buspirone or one of its pharmaceutically acceptable salts. Its application is for the treatment of pain.

ARP000104630 2000-09-05 2000-09-05 A NEW PHARMACEUTICAL ASSOCIATION THAT PRESENTS AN ANALGESIC EFFECT AR025498A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ARP000104630 AR025498A1 (en) 2000-09-05 2000-09-05 A NEW PHARMACEUTICAL ASSOCIATION THAT PRESENTS AN ANALGESIC EFFECT

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ARP000104630 AR025498A1 (en) 2000-09-05 2000-09-05 A NEW PHARMACEUTICAL ASSOCIATION THAT PRESENTS AN ANALGESIC EFFECT

Publications (1)

Publication Number Publication Date
AR025498A1 true AR025498A1 (en) 2002-11-27

Family

ID=45570789

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000104630 AR025498A1 (en) 2000-09-05 2000-09-05 A NEW PHARMACEUTICAL ASSOCIATION THAT PRESENTS AN ANALGESIC EFFECT

Country Status (1)

Country Link
AR (1) AR025498A1 (en)

Similar Documents

Publication Publication Date Title
ES2162517T3 (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES A COMBINATION OF METFORMIN AND FIBRATE AND ITS USE IN THE PREPARATION OF DRUGS INTENDED TO REDUCE HYPERGLYCEMIA.
MX9200992A (en) PHARMACEUTICAL COMPOSITION THAT HAS AS ACTIVE INGREDIENT 3- [2- (DIMETHYLAMINE) ETHYL] -N-METHYL-1H-INDOL-5-METHANOSULFONAMIDE AND PROCEDURE FOR ITS PREPARATION.
HUP0203623A2 (en) Delayed-action form of administration containing tramadol saccharinate and its use
RS50091B (en) Use of retigabine for the treatment of neuropathic pain
TR200002786T2 (en) A new galenic formulation for meloxicam.
SE9500422D0 (en) New oral pharmaceutical dosage forms
ATE514418T1 (en) RAPIDLY DISRUPTING SOLID DOSAGE FORMS WITH NON-FRUABLE CONSISTENCY AND PULLULAN
SE9600072D0 (en) New oral formulation of two active ingredients II
AR032132A1 (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES A COMBINATION OF A TRAMADOL COMPOUND AND ANTI-CONVULSIVE DRUG AND USE OF THE COMBINATION TO PREPARE A MEDICINAL PRODUCT
AR026610A1 (en) A PIRROLIDINACETAMIDE DERIVATIVE ONLY OR IN COMBINATION FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS
ES2167061T3 (en) DOSAGE FORMS TO IMPROVE ERECTILE DYSFUNCTION IN MALE SEX PATIENTS.
CL2009001279A1 (en) Nociceptin derived compounds; pharmaceutical composition comprising said compound; and use of the compound for the treatment of pain (sol. divisional 2103-03).
CL2008003941A1 (en) Use of escitalopram or a pharmaceutically acceptable salt thereof to prepare a drug useful in the treatment of obsessive compulsive disorder.
ES2192234T3 (en) PARENTERAL PHARMACEUTICAL COMPOSITIONS CONTAINING SALTS OF 2-ARILPROPIONIC ACIDS.
ATE260650T1 (en) ORAL DOSAGE FORMS FOR ADMINISTRATION OF A FIXED COMBINATION OF TRAMADOL AND DICLOFENAC
DK1345595T3 (en) Ion strength-independent pharmaceutical formulation with depot release
DE60102590T2 (en) PHARMACEUTICAL FORMS FOR THE TREATMENT OF ORAL MYCOSES
EA200600603A1 (en) ORAL SYSTEM OF DELIVERY OF DRUGS
AR023687A1 (en) A COMPOSITION FOR THE TREATMENT OF EXTERNAL RETINA DISORDERS AND THE USE OF A GLUTAMATE ANTAGONIST FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF EXTERNAL RETINA DISORDERS
ES2193065T3 (en) NEW USE OF THE SAREDUTANT.
AR028448A1 (en) FORMULATIONS CONTAINING A GLUCOCORTICOID DRUG FOR THE TREATMENT OF BRONCOPULMONARY DISEASES
NO20073575L (en) Pharmaceutical compositions for the treatment of cellulite
ES2195538T3 (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES A COMBINATION OF ISOMEROS DEXTRO AND LEVO DE SOTALOL.
AR006281A1 (en) USE OF (+) - ALPHA- (2,3-DIMETOXIFENIL) -1- [2- (4-FLUOROFENIL) ETIL] -4- PIPERIDINOMETANOL OR ITS ADDITIONAL SALTS OF PHARMACEUTICALLY ACCEPTABLE ACIDS IN THE TREATMENT OF DEPRESSIVE AND DEPRESSIVE DISORDERS
SE0001916D0 (en) Novel formulation

Legal Events

Date Code Title Description
FB Suspension of granting procedure